Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: A critical review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: A critical review

Published:2018-03 Issue: Volume:123 Page:21-41
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Savina Marion,Gourgou Sophie,Italiano Antoine,Dinart Derek,Rondeau Virginie,Penel Nicolas,Mathoulin-Pelissier Simone,Bellera Carine

Funder

Institut National du Cancer

Aquitaine League Against Cancer

SIRIC BRIO

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference93 articles.

1. Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis;Adunlin;Breast Cancer Res. Treat.,2015

2. Modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate;Advanced Colorectal Cancer Meta-Analysis Project;J. Clin. Oncol.,1992

3. Meta-analysis of randomized trials testing the biochemical modulation of 5-fluorouracil by methotrexate in metastatic colorectal cancer;Advanced Colorectal Cancer Meta-Analysis Project;J. Clin. Oncol.,1994

4. Evaluating time to cancer recurrence as a surrogate marker for survival from an information theory perspective;Alonso;Stat. Methods Med. Res.,2008

5. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J. Clin. Oncol.,2010

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accelerated Approval for Cancer Drugs in the United States and the Clinical Evidence Required for Conversion to Regular Approval;Journal of Pharmaceutical Innovation;2024-09-04

2. Surrogate endpoints in phase III randomized trials of advanced gastroesophageal cancer: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2024-09

3. Brief Communication: Treatment Outcomes for Advanced Melanoma of Unknown Primary Compared With Melanoma With Known Primary;Journal of Immunotherapy;2024-08-29

4. CT-based peritumoral radiomics nomogram on prediction of response and survival to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma;Journal of Cancer Research and Clinical Oncology;2024-01-29

5. Evaluation of progression-free survival as a surrogate end point in primary CNS lymphoma: a systematic review and meta-analysis;Future Oncology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3